Molecular mechanisms of reverse cholesterol transport

Current Opinion in Lipidology

Volumn 7, Issue 2, 1996, Pages 82-87

  Barter, Philip J ^a,c   Rye, Kerry Anne ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

CELL SECRETION; CHOLESTEROL TRANSPORT; ELECTROPHORETIC MOBILITY; EXTRACELLULAR FLUID; HUMAN; INTERSTITIAL FLUID; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029931463     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199604000-00006     Document Type: Review

References (33)

1. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-228. An excellent review of the molecular events involved in cholesterol transport. It provides a personal view of the process by a group which has contributed much over a long period to the understanding of this complex pathway.
2. Brouillette CJ, Anantharamaiah GM: Structural models of human apolipoprotein A-I. Biochim Biophys Acta 1995, 1256:103-129. A state of the art review of apoA-I structure. The authors present much information that is essential for an understanding of the role played by apoA-I in RCT.
3. Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC: Apolipoproteins, membrane cholesterol domains and the regulation of cholesterol efflux. J Lipid Res 1992, 33:1091-1097.
4. Davidson WS, Lund-Katz S, Johnson WJ, Anantharamaiah GM, Palgunachari MN, Segrest JP, Rothblat GH, Phillips MC: The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J Biol Chem 1994, 269:22975-22982. A synthetic, 18 amino acid, amphipathic, α-helical, peptide which mimics the lipid-binding properties of HDL apolipoproteins has been exploited to demonstrate that α-helical domains of apolipoproteins play an important role in their ability to promote cholesterol efflux from cells.
5. Kanellis P, Romans AY, Johnson BJ, Kercret H, Chiovetti R, Allen TM, Segrest JB. Studies of synthetic peptides analogs of the amphipathic helix. Effect of charged amino acid topography on lipid affinity. J Biol Chem 1980, 255:11464-11472.
6. ••] have demonstrated that a peptide with an amino acid sequence distinct from HDL apolipoproteins but with an α-helical domain comparable to HDL apolipoproteins is able to mimic apoA-I both in binding to cell surface binding sites and in clearing cholesterol from cells.
7. Lagrost L, Dengremont C, Athias A, de Geitere C, Fruchart J-C, Lallemant C, Gambert P, Castro G: Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. J Biol Chem 1995, 270:13004-13009. This study provides convincing evidence of the superiority of A-I HDL over A-I/A-II HDL or A-II HDL as acceptors of cell cholesterol.
8. Huang Y, von Eckardstein A, Wu S, Assmann G: Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler Thromb Vasc Biol 1995, 15: 1412-1418. Incubation of fibroblasts with whole plasma showed that A-I HDL are preferred over A-I/A-II HDL not only as acceptors of cell cholesterol but also as substrates for the LCAT-mediated esterification of cell-derived cholesterol.
9. Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC: Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995, 36:1058-1065. This study demonstrates that replacement of up to 50% of the apoA-I in HDL by the acute-phase reactant SAA, has no apparent effect on the ability of the HDL to promote cell cholesterol efflux. When virtually all of the HDL apoA-I has been replaced by SAA, the ability of the resulting HDL to promote cholesterol efflux is reduced by about 30%.
10. Davidson WS, Gillotte KL, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC: The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem 1995, 270:5882-5890. An important study showing that HDL phospholipid composition influences the effectiveness of HDL as acceptors of cell cholesterol.
11. Ohta T, Saku K, Takara K, Nakamura R, Ikeda Y, Matsuda I: Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. Arterioscler Thromb Vasc Biol 1995, 15:956-962. This study of A-I HDL demonstrates major differences between large and small particles in their ability to promote cell cholesterol efflux. Whereas small and medium sized A-I HDL are effective cholesterol acceptors, larger particles are not. In fact, the larger A-I HDL actually inhibit the efflux promoted by smaller particles.
12. Barter PJ, Hopkins GJ, Gorjatschko L: Lipoprotein substrates for plasma cholesterol esterification: influence of particle size and composition of the high density lipoprotein subfraction-3. Atherosclerosis 1995, 58:97-107.
13. Castro GR, Fielding CJ: Early incorporation of cell-derived cholesterol into prebeta-migrating high density lipoproteins. Biochemistry 1988, 27:25-29.
14. Asztalos BF, Sloop CH, Wong L, Roheim PS: Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations. Biochim Biophys Acta 1993, 1169:291-300.
15. Asztalos BF, Sloop CH, Wong L, Roheim PS: Comparison of apoA-I-containing subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration of subpopulations in the interstitial space. Biochim Biophys Acta 1993, 1169:301-304.
16. Sviridov D, Fidge N: Pathway of cholesterol efflux from human hepatoma cells. Biochim Biophys Acta 1995, 1256:210-220. It is reported that, as is the case with fibroblasts, pre-β-1 HDL are an initial acceptor of the cholesterol released from HepG2 cells.
17. Huang Y, von Eckardstein A, Wu S, Maeda N, Assmann G: A plasma lipoprotein containing only apoE and with gamma-mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA 1994, 91: 1834-1838.
18. Kawano M, Miida T, Fielding CJ, Fielding PE: Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipids. Biochemistry 1993, 32:5025-5028.
19. Fielding PE, Kawano M, Catapano AL, Zoppo A, Marcovina S, Fielding CJ: Unique epitope of apolipoprotein A-I expressed in pre-β-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry 1994, 33:6981-6985.
20. von Eckardstein A, Huang Y, Wu S, Funke H, Noseda G, Assmann G: Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. Arterioscler Thromb Vasc Biol 1995, 15: 691-703. Plasma samples from patients with HDL deficiency states have been incubated with fibroblasts in studies that highlight the importance of minor subpopulalions of pre-β-migrating, apoA-I containing HDL and γ-migrating, apoE containing HDL as acceptors of cell cholesterol.
21. Stein O, Stein Y: The removal of cholesterol from Landschutz ascites cells by high-density apolipoprotein. Biochim Biophys Acta 1973, 326:232-244.
22. Hara H, Yokoyama S: Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 1991, 266:3080-3086.
23. Bielicki JK, Johnson WJ, Weinberg RB, Glick JM, Rothblat GH: Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res 1992, 33:1699-1709.
24. Kritharides L, Jessup W, Mander EL, Dean RT: Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol 1995, 15:276-289. Lipid-fre apoA-I has been shown to accept both cholesterol and 7-ketocholesterol from macrophages which have been loaded with oxidised LDL.
25. Asztalos BF, Roheim PS: Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler Thromb Vasc Biol 1995, 15:1419-1423. In this study dilution of plasma converted pre-β-1 HDL into what appeared to be lipid-free apoA-I. A small amount of this 'lipid-free' apoA-I was also identifiable in undiluted plasma.
26. Liang H-Q, Rye K-A, Barter PJ: Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J. Lipid Res 1994, 35:1187-1199.
27. Horowitz BS, Goldberg IJ, Marab J, Vanni T, Ramatrishnan R, Ginsberg HN: Role of the kidney in increased clearance of apolipoprotein A-I in subjects with reduced high density lipoprotein cholesterol concentrations. In High density lipoproteins and atherosclerosis III. Edited by Miller NE, Tall AR. New York: Excerpta Medica; 1992:215-222.
28. Liang H-Q, Rye K-A, Barter PJ: Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta 1995, 1257:31-37. Lipid-free apoA-I was generated by incubating HDL with CETP plus either VLDL or LDL. The dissociated apoA-I was reincorporated into HDL during subsequent incubation with LCAT which increased the cholesteryl ester content and particle size of the HDL.
29. Clay MA, Newnham HH, Forte TM, Barter PJ: Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apoA-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992, 1124:52-58.
30. Forte TM, Bielicki JK, Goth-Goldstein R, Selmek J, McCall MR: Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res 1995, 36:148-157. Lipid-free apoA-I and apoA-II have been incubated with Chinese hamster ovary cells and shown to be incorporated into discoidal HDL particles. The A-I HDL, but not the A-II HDL, were shown to be further modified by LCAT.
31. Czarnecka H, Yokoyama S: Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry 1995, 34:4385-4392. Incubation of lipid-free apoA-I and apoA-II with macrophages and fibroblasts generated pre-β HDL. Although the newly formed A-I HDL were reactive with LCAT, the presence of LCAT did not enhance the efflux of cell cholesterol into the apoA-I-containing particles. LCAT did, however, inhibit the influx of cholesterol from HDL to cells, thus accounting for the ability of the enzyme to enhance the net efflux of cell cholesterol.
32. Rye K-A, Garrety KH, Barter PJ: Preparation and characterization of spheroidal, reconstituted high density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II. Biochim Biophys Acta 1993, 1167:316-325.
33. Kilsdonk EPC, Yancy PG, Stoudt GW, Bangerter FW, Johnson WJ, Phillips MC, Rothblat GH: Cellular cholesterol efflux medicated by cyclodextrins. J Biol Chem 1995, 260:17250-17256. This important study demonstrates the ability of cyclodextrins to accept cell cholesterol. Cyclodextrins are water-soluble, cyclic oligosaccharides which contain a hydrophobic cavity able to accommodate lipids. Cyclodextrins are proposed as potential pharmacologic anti-atherogenic agents.